Changzhou Qianhong Biopharma (002550) Stock Overview

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers its products in the form of tablets, hard capsules, lyophilized powder and lyophilized powder injections, small-volume injections, and raw materials. It provides enzymes, including pancreatic kininogenase series, asparaginase series, and compound digestive enzyme capsule II; and polysaccharides products, such as nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium. The company also offers nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium injections. In addition, it exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.